| Product Code: ETC7661533 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Sedative-Hypnotic Drugs Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Sedative-Hypnotic Drugs Market - Industry Life Cycle |
3.4 Israel Sedative-Hypnotic Drugs Market - Porter's Five Forces |
3.5 Israel Sedative-Hypnotic Drugs Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Israel Sedative-Hypnotic Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Israel Sedative-Hypnotic Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Israel Sedative-Hypnotic Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Israel Sedative-Hypnotic Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Sedative-Hypnotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of insomnia and other sleep disorders in Israel |
4.2.2 Rising awareness about mental health and need for sedative-hypnotic drugs |
4.2.3 Growing geriatric population in Israel requiring sleep aids |
4.3 Market Restraints |
4.3.1 Stringent regulatory environment governing the use of sedative-hypnotic drugs in Israel |
4.3.2 Potential side effects and dependency issues associated with prolonged use of sedatives |
4.3.3 Competition from alternative therapies such as cognitive behavioral therapy for insomnia |
5 Israel Sedative-Hypnotic Drugs Market Trends |
6 Israel Sedative-Hypnotic Drugs Market, By Types |
6.1 Israel Sedative-Hypnotic Drugs Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Sleep Disorders, 2021- 2031F |
6.1.4 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Anaesthesia, 2021- 2031F |
6.1.5 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Pain, 2021- 2031F |
6.1.6 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Sedative-Hypnotic Drugs Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Benzodiazepines, 2021- 2031F |
6.2.3 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Barbiturates, 2021- 2031F |
6.2.4 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Antihistamines, 2021- 2031F |
6.2.5 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Nonbenzodiazepine, 2021- 2031F |
6.2.6 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Sedative-Hypnotic Drugs Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Sedative-Hypnotic Drugs Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Sedative-Hypnotic Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.5 Israel Sedative-Hypnotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Sedative-Hypnotic Drugs Market Import-Export Trade Statistics |
7.1 Israel Sedative-Hypnotic Drugs Market Export to Major Countries |
7.2 Israel Sedative-Hypnotic Drugs Market Imports from Major Countries |
8 Israel Sedative-Hypnotic Drugs Market Key Performance Indicators |
8.1 Number of prescriptions for sedative-hypnotic drugs in Israel |
8.2 Patient adherence rates to sedative-hypnotic drug therapy |
8.3 Adoption rate of newer sedative-hypnotic drug formulations |
8.4 Physician recommendations for sedative-hypnotic drugs |
8.5 Patient satisfaction and reported outcomes with sedative-hypnotic drug therapy |
9 Israel Sedative-Hypnotic Drugs Market - Opportunity Assessment |
9.1 Israel Sedative-Hypnotic Drugs Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Israel Sedative-Hypnotic Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Israel Sedative-Hypnotic Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Israel Sedative-Hypnotic Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Israel Sedative-Hypnotic Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Sedative-Hypnotic Drugs Market - Competitive Landscape |
10.1 Israel Sedative-Hypnotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Israel Sedative-Hypnotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here